|

Continuous DOAC therapy Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Oral Anticoagulation therapy

Pipeline

Phase 3: 1

Top Sponsors

  • Johns Hopkins University1

Indications

  • Heart Disease1
  • Atrial Fibrillation1

Phoenix, Arizona1 trial

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

Banner University

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.